文献速递神经儿科影像MRUS

模拟COL4A1/COL4A2胎儿脑表型的罕见代谢病

Rare metabolic disease mimicking COL4A1/COL4A2 fetal brain phenotype.
PubMed 文献 · Ultrasound Obstet Gynecol · 2022-01-01

对113例因疑似脑内出血转诊行COL4A1/COL4A2分子筛查但靶向测序阴性的胎儿进行外显子组测序,发现PDHA1基因罕见变异显著富集(P=2.11×10-7),3例女性胎儿携带PDHA1功能丧失变异,其影像和尸检表现与COL4A1/COL4A2相关表型重叠。

要点

  • COL4A1/COL4A2筛查阴性的胎儿脑内出血或发育异常,需考虑PDHA1相关代谢病可能。
  • PDHA1变异胎儿可表现为小头、脑室扩大、生发基质假性囊肿及胼胝体发育异常。
  • 这些表现与COL4A1/COL4A2相关脑表型重叠,后验分析易混淆。

核心结论

  • 在COL4A1/COL4A2分子筛查阴性的胎儿中,PDHA1功能丧失变异显著富集,其影像和尸检表型与COL4A1/COL4A2相关脑表型重叠,因此建议对筛查阴性者行外显子组测序并关注PDHA1基因。

研究设计与样本

  • 对113例无关胎儿(终止妊娠或宫内死亡后)行外显子组测序和基于基因的 collapsing 检验,与gnomAD对照队列(n=71 702)比较罕见合格变异的富集。

关键影像表现/征象

  • 3例女性胎儿携带PDHA1杂合功能丧失变异,均可见小头畸形、脑室扩大、生发基质假性囊肿、胼胝体缺如/发育不良及白质异常。
  • 上述病变最初提示脑缺氧缺血性和出血性损伤,后验分析显示与PDHA1致病变异胎儿所见一致。

诊断标准与关键数值

  • PDHA1合格变异在胎儿队列中富集达到全基因组显著性(P=2.11×10-7)。

临床应用与阅片要点

  • 对因疑似脑内出血转诊行COL4A1/COL4A2分子筛查且结果为阴性的胎儿,应行外显子组测序并特别关注PDHA1基因。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pathogenic variants of collagen type IV alpha 1 and 2 (COL4A1/COL4A2) genes cause various phenotypic anomalies, including intracerebral hemorrhage and a wide spectrum of developmental anomalies. Only 20% of fetuses referred for COL4A1/COL4A2 molecular screening (fetuses with a suspected intracerebral hemorrhage) carry a pathogenic variant in these genes, raising questions regarding the causative anomaly in the remaining 80% of these fetuses. We examined, following termination of pregnancy or in-utero fetal death, a series of 113 unrelated fetuses referred for COL4A1/COL4A2 molecular screening, in which targeted sequencing was negative. Using exome sequencing data and a gene-based collapsing test, we searched for enrichment of rare qualifying variants in our fetal cohort in comparison to the Genome Aggregation Database (gnomAD) control cohort (n = 71 702). Qualifying variants in pyruvate dehydrogenase E1 subunit alpha 1 (PDHA1) were overrepresented in our cohort, reaching genome-wide significance (P = 2.11 × 10-7 ). Heterozygous PDHA1 loss-of-function variants were identified in three female fetuses. Among these three cases, we observed microcephaly, ventriculomegaly, germinolytic pseudocysts, agenesis/dysgenesis of the corpus callosum and white-matter anomalies that initially suggested cerebral hypoxic-ischemic and hemorrhagic lesions. However, a careful a-posteriori reanalysis of imaging and postmortem data showed that the observed lesions were also consistent with those observed in fetuses carrying PDHA1 pathogenic variants, strongly suggesting that these two phenotypes may overlap. Exome sequencing should therefore be performed in fetuses referred for COL4A1/COL4A2 molecular screening which are screen-negative, with particular attention paid to the PDHA1 gene. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Coste T, Aloui C, Petit F, et al. Rare metabolic disease mimicking COL4A1/COL4A2 fetal brain phenotype. Ultrasound Obstet Gynecol. 2022. PMID: 35943828. doi:10.1002/uog.26046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。